Health Canada has accepted a marketing authorisation application for the Belgian pharmaceutical company Mithra’s complex therapeutic Tibelia, a tibolone-based product, to be used in hormone therapy (HT).
Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc., announced Health Canada has approved Cerdelga (eliglustat capsules) for the treatment of adult patients with Gaucher Disease Type 1.